Safety Profile of and Patient Preference for Shorter Ocrelizumab Infusion
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial
J Neurol 2024 Apr 22;[EPub Ahead of Print], HP Hartung, T Berger, RA Bermel, B Brochet, WM Carroll, T Holmøy, R Karabudak, J Killestein, C Nos, F Patti, A Perrin Ross, L Vanopdenbosch, T Vollmer, R Buffels, M Garas, K Kadner, M Manfrini, Q Wang, MS FreedmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.